Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Chardan Capital's Rating of Zapata Quantum on 10/13/2026

On October 13, 2026, Chardan Capital updated its outlook on Zapata Quantum (OTCMKTS:ZPTA) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Chardan Capital

DateCompanyAction
10/23/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Reiterated Rating
10/22/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
Reiterated Rating
10/22/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Reiterated Rating
10/22/2026
Agenus Inc. stock logo
AGEN
Agenus
Reiterated Rating
10/22/2026
Kodiak AI, Inc. stock logo
KDK
Kodiak AI
Lower Price Target
10/21/2026
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
Downgrade
More Ratings From Chardan Capital